Exjade® (deferasirox) – PRODUCT INFORMATION

Overview | Product Information | Accredo Services | Contact Team

EXJADE is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.

EXJADE tablets are dissolved in water, orange juice or apple juice and the mixture is taken 30 minutes prior to consuming any food.

For more information, please download the full prescribing information.

Exjade is a registered trademark of Novartis Pharmaceuticals Corporation.